|
|
Volumn 75 Suppl 1, Issue , 2007, Pages 62-68
|
|
Novel measurement of rapid treatment success with ReQuest: first and sustained symptom relief as outcome parameters in patients with endoscopy-negative GERD receiving 20 mg pantoprazole or 20 mg esomeprazole.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE;
OMEPRAZOLE;
PANTOPRAZOLE;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONFIDENCE INTERVAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG ADMINISTRATION;
ESOPHAGOSCOPY;
FEMALE;
FOLLOW UP;
GASTROESOPHAGEAL REFLUX;
GASTROSCOPY;
HOSPITALIZATION;
HUMAN;
MALE;
MIDDLE AGED;
MULTICENTER STUDY;
PROBABILITY;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
STANDARD;
TIME;
TREATMENT OUTCOME;
2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES;
ADULT;
AGED;
CONFIDENCE INTERVALS;
CROSS-OVER STUDIES;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOUBLE-BLIND METHOD;
DRUG ADMINISTRATION SCHEDULE;
ESOPHAGOSCOPY;
FEMALE;
FOLLOW-UP STUDIES;
GASTROESOPHAGEAL REFLUX;
GASTROSCOPY;
HUMANS;
MALE;
MIDDLE AGED;
OMEPRAZOLE;
PROBABILITY;
QUALITY OF LIFE;
QUESTIONNAIRES;
SEVERITY OF ILLNESS INDEX;
TIME FACTORS;
TREATMENT OUTCOME;
|
|
EID: 34347373124
PISSN: None
EISSN: 14219867
Source Type: Journal
DOI: 10.1159/000101084 Document Type: Article |
|
Times cited : (9)
|
|
References (0)
|
